Center-Authored Papers

Filters: Author is Carpenter, Janet S  [Clear All Filters]
Journal Article
Sternfeld B, Lacroix A, Caan BJ, Dunn AL, Newton KM, Reed SD, Guthrie KA, Booth-Laforce C, Sherman KJ, Cohen L et al..  2013.  Design and methods of a multi-site, multi-behavioral treatment trial for menopausal symptoms: The MsFLASH experience.. Contemporary clinical trials. 35(1):25-34. Abstract
Carpenter JS, Guthrie KA, Larson JC, Freeman EW, Joffe H, Reed SD, Ensrud KE, LaCroix AZ.  2012.  Effect of escitalopram on hot flash interference: a randomized, controlled trial.. Fertility and sterility. 97(6):1399-1404.e1. Abstract
LaCroix AZ, Freeman EW, Larson J, Carpenter JS, Joffe H, Reed SD, Newton KM, Seguin RA, Sternfeld B, Cohen L et al..  2012.  Effects of escitalopram on menopause-specific quality of life and pain in healthy menopausal women with hot flashes: A randomized controlled trial.. Maturitas. Abstract
Caan B, LaCroix AZ, Joffe H, Guthrie KA, Larson JC, Carpenter JS, Cohen LS, Freeman EW, Manson JE, Newton K et al..  2014.  Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes: a placebo-controlled randomized trial.. Menopause (New York, N.Y.). Abstract
Freeman EW, Guthrie KA, Caan B, Sternfeld B, Cohen LS, Joffe H, Carpenter JS, Anderson GL, Larson JC, Ensrud KE et al..  2011.  Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial.. JAMA : the journal of the American Medical Association. 305(3):267-74. Abstract
Sternfeld B, Guthrie KA, Ensrud KE, LaCroix AZ, Larson JC, Dunn AL, Anderson GL, Seguin RA, Carpenter JS, Newton KM et al..  2014.  Efficacy of exercise for menopausal symptoms: a randomized controlled trial.. Menopause (New York, N.Y.). 21(4):330-8. Abstract
Cohen LS, Joffe H, Guthrie KA, Ensrud KE, Freeman M, Carpenter JS, Learman LA, Newton KM, Reed SD, Manson JE et al..  2014.  Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial.. Menopause (New York, N.Y.). 21(4):347-54. Abstract
Newton KM, Reed SD, Guthrie KA, Sherman KJ, Booth-Laforce C, Caan B, Sternfeld B, Carpenter JS, Learman LA, Freeman EW et al..  2014.  Efficacy of yoga for vasomotor symptoms: a randomized controlled trial.. Menopause (New York, N.Y.). 21(4):339-46. Abstract
Carpenter JS, Jones SMW, Studts CR, Heiman JR, Reed SD, Newton KM, Guthrie KA, Larson JC, Cohen LS, Freeman EW et al..  2016.  Female Sexual Function Index Short Version: A MsFLASH Item Response Analysis.. Archives of sexual behavior. Abstract
Joffe H, Guthrie KA, LaCroix AZ, Reed SD, Ensrud KE, Manson JE, Newton KM, Freeman EW, Anderson GL, Larson JC et al..  2014.  Low-Dose Estradiol and the Serotonin-Norepinephrine Reuptake Inhibitor Venlafaxine for Vasomotor Symptoms: A Randomized Clinical Trial.. JAMA internal medicine. Abstract
Reed SD, Guthrie KA, Newton KM, Anderson GL, Booth-Laforce C, Caan B, Carpenter JS, Cohen LS, Dunn AL, Ensrud KE et al..  2013.  Menopausal quality of life: RCT of yoga, exercise, and omega-3 supplements.. American journal of obstetrics and gynecology. Abstract
Newton KM, Carpenter JS, Guthrie KA, Anderson GL, Caan B, Cohen LS, Ensrud KE, Freeman EW, Joffe H, Sternfeld B et al..  2014.  Methods for the design of vasomotor symptom trials: the Menopausal Strategies: Finding Lasting Answers to Symptoms and Health network.. Menopause (New York, N.Y.). 21(1):45-58. Abstract
Freeman EW, Ensrud KE, Larson JC, Guthrie KA, Carpenter JS, Joffe H, Newton KM, Sternfeld B, LaCroix AZ.  2015.  Placebo improvement in pharmacologic treatment of menopausal hot flashes: time course, duration, and predictors.. Psychosomatic medicine. 77(2):167-75. Abstract
Guthrie KA, LaCroix AZ, Ensrud KE, Joffe H, Newton KM, Reed SD, Caan B, Carpenter JS, Cohen LS, Freeman EW et al..  2015.  Pooled Analysis of Six Pharmacologic and Nonpharmacologic Interventions for Vasomotor Symptoms.. Obstetrics and gynecology. 126(2):413-22. Abstract
Joffe H, Guthrie KA, Larson J, Cohen LS, Carpenter JS, LaCroix AZ, Freeman EW.  2012.  Relapse of vasomotor symptoms after discontinuation of the selective serotonin reuptake inhibitor escitalopram: results from the Menopause Strategies: Finding Lasting Answers for Symptoms and Health Research Network.. Menopause (New York, N.Y.). Abstract
Joffe H, Guthrie KA, Larson J, Cohen LS, Carpenter JS, LaCroix AZ, Freeman EW.  2013.  Relapse of vasomotor symptoms after discontinuation of the selective serotonin reuptake inhibitor escitalopram: results from the menopause strategies: finding lasting answers for symptoms and health research network.. Menopause (New York, N.Y.). 20(3):261-8. Abstract
Fugate Woods N, Hohensee C, Carpenter JS, Cohen L, Ensrud K, Freeman EW, Guthrie KA, Joffe H, LaCroix AZ, Otte JL.  2015.  Symptom clusters among MsFLASH clinical trial participants.. Menopause (New York, N.Y.). Abstract
Carpenter JS, Reed SD, Guthrie KA, Larson JC, Newton KM, Lau JR, Learman LA, Shifren JL.  2015.  Using an FSDS-R Item to Screen for Sexually Related Distress: A MsFLASH Analysis.. Sexual medicine. 3(1):7-13. Abstract
Carpenter JS, Bakoyannis G, Otte JL, Chen CX, Rand KL, Woods N, Newton K, Joffe H, Manson JE, Freeman EW et al..  2017.  Validity, cut-points, and minimally important differences for two hot flash-related daily interference scales.. Menopause (New York, N.Y.). Abstract